To avoid risk to laboratory personnel, we typically use small tanks of NO in a fume hood located in a well-ventilated room. During the process of saturating a solution with NO, vented NO is bubbled through a series of gas scrubbers containing a solution of basic potassium permanganate, which oxidizes NO preventing its escape to the atmosphere.
A gas mask is available in case of leakage.
MEASUREMENT OF NITRIC OXIDE

General
Measurement of NO in biological specimens is difficult both because of the small amounts present (usually than nanomolar) and the lability of NO in the presence of 02. This instability is partially ameliorated by adding superoxide dismutase to the medium in which NO is to be measured (20 cyclic GMP to document that a detected NO signal was sufficient to stimulate guanylate cyclase. All three types of indirect tests are useful and provide corroborative information about NO; however, none is sufficiently specific to be considered a "stand alone" assay for NO.
Although a discussion of the cyclic GMP assay is beyond the scope of this review, it is important to point out that cy- found that although the chemiluminescence assay readily detected NO production by pulmonary artery rings after treatment with the ionophore A23187, acidification increased the size of the NO signal 7-to 13-fold. A similar "specificity concern" applies to the use of reducing agents such as sodium or potassium iodide (KI) to enhance NO detection.
As stated by Aoki (46), "sample collection under strong reducing conditions would result in substantially higher levels of NO by chemiluminescence due to the reduction of biologicallyactiveas well as inactive NO compounds"
Aoki studied the effectsof varying KI concentration on the observed NO production from nitrite by using a chemiluminescence assay. He found that production of NO from nitriteoccurred in direct proportion to the dose of KI used, up to a plateau KI concentration of 1 M. Consequently, he recommended that when KI was used it be given at a dose of I M to reduce variability in the degree of conversion of nitrite to NO. (Fig. 1) . In addition to a PMT and ozone generator, one must have a sample chamber in which NO can be held, and if necessary stripped into the gas phase.
A glass purge chamber (Sievers Research, Inc., Boulder, Cob.) that has a fit in its floor to permit stripping of liquid specimens is useful for this purpose (Fig. 1 ). This purge chamber has an inflow linefor delivery of an inert gas to the fit and an outflow line to carry the gas in the head space to Figure   1 . Schematic representation of a nitric oxide analyzer designed to measure nitric oxide using the chemiluminescence assay.PMT, photomultiplier tube. (Fig. 2) . A NO dose/chemiluminescence curve must be constructed for each integration time.
Sensitivity/detection threshold
Zafiriou and McFarland (47) reported that the chemiluminescence assay is sensitive to 10-M NO. However, most investigators find the sensitivitythreshold for detection of NO is 20-50 pmol (6,20, 48) (Fig.2) . Several authors have noted that the chemiluminescence/NO curve islinearbetween NO doses of 300 and 3000 pmol (34, 48). We have found the NOchemiluminescence relationship to be linear between 20 and 200 pmol but somewhat nonlinear at higher concentrations (Fig. 2) . The sensitivity of the assay for authentic NO is not dramatically affected by the use of reducing agents or acids if done properly, for unlike measurements in biological NO DOSE (pmole) Figure 2 . Sensitivity of the chemiluminescence assayfordetectionof nitric oxide gas (in vitro). Doses of authentic nitric oxide gas were measured at room temperature using chemiluminescence in the presence of saline (control), acetic acid, and hydrochloric acid Vol. 7
February 1993
The FASEB Journal ARCHER (Fig. 2) . A number of features of the chemiuminescence assay merit discussion.
Specificity
Cooled PMT
The PMT should be "red-sensitive," as the light emission resulting from the interactionof ozone and NO occurs between 660 and 900 nm (47). Cooling the PMT greatly improves the signal/noise ratio.
Vacuum in the purge apparatus (Fig. 1)
In 02-free solutions,NO isstablefor days and gradually deteriorates by interaction with tiny contaminating amounts of oxygen and by thermodynamic disproportionation (Table 2) ; however, in the presence of 02, NO recovery is diminished by roughly 50% in 8-20 mm (47). Consequently, it is essential to keep samples free from 02. When the sample, whether gas or liquid, is injected into the purge apparatus, the vacuum (P02 3 mm Hg) stops or slows any conversion to nitrite or nitrogen dioxide (Fig. I) .
In-line drier
Chemiluminescence estimates of NO levels are depressed 10-15% when the sample is measured at 100% humidity.
Drying of the gaseous sample isessentialto remove the water vapor, which quenches NO25 (47). 
DIAZOTIZATION ASSAY
Methods
The basic assay (7) is designed to measure single samples, but itcan be modified to give "on-line"results(28). In the basic assay (7) the sample is placed in a vesselcontaining 4 N HCI. An aliquot is withdrawn and incubated for 10 mm with a mixture of 2 N HC1 and sulfanilic acid (2 mg/mb). N- triphosphate ATP, or A23187) was split, so that part was delivered to a bioassay (a denuded aortic ring) and the remainder to a spectrophotometer. The diazotization assay was performed en route to the spectrophotometer. Perfusate destined for the spectrophotometer (1.2 ml/min) was mixed first with 2 M HC1 and then sulfaniic acid (0.7 mg/ml) was added. This mixture was passed through a 3.5 mm delay coil and then N-(l-naphthyb)ethylenediamine (0.7 mg/mb) was added. All reagents were infused at 0.3 mb/mm. After passing through a 6 mm delay coil,the mixture entered the spectrophotometer and the absorbances at 548 nm were compared to baseline (the absorption measured with all reagents present, but before adding EDRF or NO) (28). The detection threshold of the diazotization assay is roughly 10 to 106 M NO (28). In this assay, absorption at 548 nm should increase solely as a function of NO dose. In fact, when using this assay on authentic NO solutions,Tracy et al. (28) found the magnitude of signal varied depended on the duration of NO bubbling used to prepare the authentic NO solution. The longer the solutions were bubbled with NO, the greater the signal noted by the diazotizationassay.In contrast,the duration of bubbling had no effecton the vasodilatorpotency of the NO solution in bioassay. They then removed the NO from the testsolutionsby bubbling it with an inert gas and made the elegant observation that bioassay activitywas, as expected, severely diminished; surprisingly, NO levels estimated from the diazotization assay were unaltered. They correctly interpreted these findings as evidence that a nonvolatile, hemodynamically inactive substance, probably NO, was accounting for much of the NO signal in the diazotizationassay. It appears that despite the use of nominally 02-free solutions,the small contaminating amounts of 02 caused conversion of NO to NO, which was biologically inactive but was con-verted to NO during the diazotizationassay by the acid pH.
Of even more concern, the administration of ATP, A23187, and BK decreased tension in aortic rings from 40 to 50% (as did authentic NO), but the EDRF failedto produce any signal in the diazotization assay. This indicates that either the diazotization assay is insufficiently sensitive to detect the amount of NO produced under these conditions or the endothelial relaxing factor in these experiments was not NO. It appears that the diazotization assay is not adequately sensitive to measure NO at submicromolar concentrations and is best considered a measure of nitrite and mixed nitroxides.
ELECTRON PARAMAGNETIC RESONANCE (EPR) ASSAY
NO is a gaseous, paramagnetic molecule with the unpaired electron in the r orbital (37). The basic principle of detecting radicals by EPR spectroscopy is that at a discrete amount of energy (microwave frequency) and magnetic field strength, unpaired electrons are promoted to higher energy levels; relaxation from this state produces a characteristic spectrum.
NO and NO2 cannot be studied by simple EPR as the relaxation time of the stimulated electron to ground state is too rapid to be detected (50). Spin traps are compounds that interact with the unstable radicals, producing a more stable adduct that can be detected by EPR. The spin traps that can be used to detect NO include the nitroxide compounds and hemoglobin (37, 38). Nitroxide traps are relatively stabilized by the resonance of the unpaired electron. There are two types of nitroxide spin traps, the nitrones and the nitroso compounds.
The nitroso compounds usually provide the best information about the identity of a radical, as the radical is added directly to the nitroso nitrogen, thereby increasing the information in the hyperfine splitting parameters (51). However, oxygen-based adducts of the nitrosocompounds are unstable and one must usually rely on the nitrones for such studies.The identityof the radical,defined by EPR, ischaracterized by the magnitude and multiplicity of the hyperfine splitting of the spin adduct's spectra.
The amount of radical present is proportional to the magnitude of the signal (50, 51).
Methods for EPR using nitroxide traps
A commercially available spectrometer is used. The magnetic field is usually set at or near 330 mT, with a microwave power of 8-10 mW, frequency of 9 GHz, and modubation am- 
Utilization
Although in principle this technique is simple, the attempt to detect NO using traps which themselves have -NO moieties is problematic.
Arroyo and Kohno (37) compared the specificity of multiple spin traps for NO and concluded that the nitroso spin traps (MNP, DBNBS) are better suited for the identification of NO-rebated signals than the nitrones (e.g., 5,5-dimethyb-pyrrobine-N-oxide (DMPO). The spectra generated by the nitrones in the presence of NO appear to result from hydrolysis of the probes and provide an inaccurate estimate of NO levels. In fact, nitrones are unstable at acid pH and tended to yield NO-type spectra even in the absence of NO (37).
Hemoglobin is also useful as a spin trap because nitrosylhemoglobin (NO-Hb) is readily measured by EPR (37, 38). NO interacts with hemoglobin, producing both NO-Hb and methemoglobin (the NO-Hb interactswith oxygen, producing further methemoglobin) (26). The 77 K spectra of NOHb has a characteristic three-line, hyperfine signalthat isnot seen when hemoglobin is exposed to other nitro compounds (e.g., NO, azide) (38). A super-hyperfine structure (triplet of a triplet) is also detectable (26). dissolving 400 l of Hb-agarose in I ml of H20) and then excess material is washed free with 10 ml of H20. The hemoglobin is reduced (manifest as a change in color from brown to purple) by the addition of dithionite (10 mg/I ml H2O) (52). The column can then be exposed to the experimental specimen and analyzed by EPR at 77 K. Like the chemiluminescence assay, the EPR NO-Hb assay can measure NO itself, or by adding dithionite or acid to the specimen, can measure combined NO and nitrite (52).
Greenberg
et al. (38) studied EDRF activity and NO production in femoral arterial rings using the N0-Hb EPR technique. The threshold for detection of authentic NO was I nM (spectra obtained at 77 K using a spectrometer operating at 9.42 GHz with 20 mW power and 100 kHz modulation frequency) (Fig. 3) . They attempted to detect NO production in response to acetylcholine by using this technique, but found no signal in the effluentfrom acetylcholine-treated femoral arteries even though ACH and the authentic NO had produced similar relaxation in the bioassay. They concluded that ACH-induced vasodilatation was not mediated by NO in the canine femoral artery. The conclusion that ACH-induced vasodilatation does not (always) occur through production of NO is supported by studies of bovine and rat pulmonary arteries using the chemiluminescence assay (20, 34).
Wang et al. (53) noted increased levels of NO-Hb in rats with endotoxic shock. They enhanced EPR-detection of NOHb by pooling the blood from several animals to increase the signal intensity.
The signal-to-noise ratio was improved by subtracting the EPR spectra from the blood of control animals (53). They reported that levels of NO-Hb did not correlate with vascular tone, an observation made previously in studies that failed to find a correlation between dilator potency of the nitrovasodilator drugs and the blood levels of NO-Hb (53). The authors discuss the hypothesis that only that fraction of NO that reaches the lumen is available for interaction with reduced hemoglobin.
The assay may therefore not have access to the pool of NO that determines vasodilator efficacy, namely, that which reaches the smooth muscle. However, this theoretical criticism applies potentially to all assays. One advantage of the N0-Hb assay over the chemibuminescence assay is the ability of the former to measure NO in blood, and unlike the diazotization assay, acidification is unnecessary, although acidification of the specimen will convert the NO-Hb EPR assay to a nitrite assay. verting nitrite to NO, and then measured EPR spectra using a spectrometer (microwave frequency 9.17 GHz, power 8 mW). Spectra were scanned from 3000 to 3500 gauss with a scan rate of 250 G/min (52). They established a "normal" venous nitrite level in humans of 0-0.6 mM and noted that ischemia greatly increased this level.
Westenberger et al. (54) detected the NO adduct of Hb in the venous blood of rats with endotoxic shock using EPR (microwave power 10 mW at 9.20 GHz, modulation amplitude 8 G). In sepsis, NO-Hb accounted for as much as 0.8% of all hemoglobin.
They found the typical three-bine hyperfine splitting of 1.75 mT at g' 2.012 and 1.6 mT at g' 2.609 "characteristic of an unpaired electron coupled to nitrogen in a ferrous heme-NO complex" (54 ppm, 20 mm every other day x 6). Unfortunately the equipment required to perform EPR is expensive and considerable expertise is necessary. In contrast, the chemiluminescence assay is easier to learn and much lesscostly. Furthermore, the interaction between NO and hemoglobin is pH dependent. Liu et al. (55) showed that at alkaline pH there was significant impairment of EPR detection of NO-Hb adduct due to inhibition of the interaction between NO and Hb (hyperfine coupling was unchanged). Hemoglobin forms a fairly stable adduct with NO that is readily detected by EPR (56) . For those with the necessary equipment and expertise, EPR, particularly using hemoglobin as a trap, is a useful means of assaying NO.
METHEMOGLOBIN SPECTROPHOTOMETRY
ASSAY
Unlike the EPR assay, this technique is based on the rapid oxidation of reduced hemoglobin (Fe2) to methemogbobmn (Fe3) by NO rather than on the detection of NO-Hb (Table  2 ). NO's oxidation of reduced hemoglobin occurs in less than 100 ms, suggesting the assay is sufficiently dynamic to study the time course of NO synthesis (39). The threshobd for detection of NO using this assay is I nM (39).
Methods
Commercially available hemoglobin is 50-95% methemogbobin (57) and must be reduced with a molar excess of dithionite. Once reduced, the hemoglobin gradually reoxidizes to methemoglobin.
Although some authors have then purified the mixture by gel chromatography using a Sephadex column (39), this is not essential. NO is detected by observing the characteristic shift in the Soret absorbance peak of hemoglobin from 433 nm to 406 nm (Fig. 4) (7) . Accumulation of oxyhemogbobin is not a probbem in this assay due to the much higher affinity of hemoglobin for NO than 02 (Table 1). Furthermore, oxyhemoglobin can be detected by its Soret peak (416 nm). Conversion of reduced to methemoglobin can be measured as the extinction difference at 401 and 411 nm (the isobestic point) (58).
Utilization
Ignarro et al. (7) detected the production of NO or a related nitrosyl product from A23187-stimulated aortic endothelial cells by using thisassay (Fig. 4) . They found that estimates (401 and 411 nm), double-beam spectrophotometer (39) equipped with a flow-through cell. They were able to document the production of NO beginning 15 s after stimulation of endothelial cells with bradykinin (peak production at I min). Kostic and Schrader (59) However, unlike the nonacidified chemiluminescence assay, which gains specificity from the volatility and water insolubility of NO, this assay might detect other nitrosyb groups in the sample.
GAS CHROMATOGRAPHY
Although
NO can be detected by standard gas chromatography techniques, this assay is much less sensitive than chemiluminescence or EPR assays (27). Pai et al (27) used a Varian gas chromatograph with a Porapak Q column and electron capture detector to measure enzymaticalby generated NO. They found that gas chromatography was much bess sensitive than chemiluminescence assay, a difference that they attributedin part to the sample processing methodology required for gas chromatography. of NO they coated the carbon fiber with Nafion, a negatively charged material that is highly impermeable to anions. Nafion-coated fibers displayed no change in current when a 20-fold excess of NO was added to the sample. This technique permitted detection of NO production from cultured endothelial and smooth muscle cells (Fig. 5) 
